Guidance
US FDA expands guidance on race, ethnicity data in trials
…standards for classifying race and ethnicity data, the U.S. FDA issued
Source link
Commentary on New Guidance for Human Papillomavirus-Related Cancer Screening Among Sexual and Gender Minority Populations.
Commentary on New Guidance for Human Papillomavirus-Related Cancer Screening Among Sexual and Gender Minority Populations.
Source link
FDA’s Industry Guidance Will Increase Racial and Ethnic Diversity in Clinical Trials
New draft guidance from the U.S. Food and Drug Administration (FDA) facilitates enrolling more participants from underrepresented racial and ethnic...
FDA Pushes Enrollment of Underrepresented Populations in Clinical Trials with Recent ‘Race and Ethnicity Diversity Plan’ Draft Guidance
Jacob Simpson
...
FDA Guidance on Diversity Plans in Clinical Trials: What You Need to Know | Bass, Berry & Sims PLC
The United States Food and Drug Administration (FDA) issued draft guidance on April 13, 2022, entitled, “Diversity Plans to Improve Enrollment of P...
FDA issues ambitious new draft guidance to promote clinical trial diversity | Hogan Lovells
FDA recommends the submission of a Plan for all medical products for which an IND submission is required or for which clinical studies are intended...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
